{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:00:09Z","timestamp":1777550409668,"version":"3.51.4"},"reference-count":48,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>PRKAR1A is the gene encoding the type 1A regulatory subunit of protein kinase A, and it is the cause of the inherited human tumor syndrome Carney complex. Data from our laboratory has demonstrated that Prkar1a loss causes tumors in multiple cell lineages, including neural crest cells and osteoblasts. We have proposed that one mechanism by which tumorigenesis occurs is through the failure of terminal differentiation. In the present study, we directly test the effects of Prkar1a reduction on osteogenic differentiation in mouse and human cells in vitro. We found that Prkar1a levels noticeably increased during osteoblastic differentiation, indicating a positive correlation between the expression of Prkar1a and osteogenic potential. To validate this hypothesis, we generated stable Prkar1a knockdown in both mouse and human cells. These cells displayed significantly suppressed bone nodule formation and decreased expression of osteoblast markers such as osteocalcin and osteopontin. These observations imply that the antiosteogenic effect of Prkar1a ablation is not species or cell line specific. Furthermore, because Runt-related transcription factor-2 (Runx2) is a key mediator of osteoblast differentiation, we reasoned that the function of this transcription factor may be inhibited by Prkar1a knockdown. Chromatin immunoprecipitation and luciferase assays demonstrated that Prkar1a ablation repressed DNA binding and function of Runx2 at its target genes. Additionally, we determined that this effect is likely due to reductions in the Runx2-cooperating transcription factors forkhead box O1 and activating transcription factor 4. Taken together, this study provides direct evidence that ablation of Prkar1a interferes with signaling pathways necessary for osteoblast differentiation.<\/jats:p>","DOI":"10.1210\/me.2013-1152","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T17:52:46Z","timestamp":1391795566000},"page":"295-307","source":"Crossref","is-referenced-by-count":16,"title":["Knockdown of PRKAR1A, the Gene Responsible for Carney Complex, Interferes With Differentiation in Osteoblastic Cells"],"prefix":"10.1210","volume":"28","author":[{"given":"Mei","family":"Zhang","sequence":"first","affiliation":[{"name":"Departments of Molecular, Virology, Immunology, and Medical Genetics (M.Z., P.K.M., L.S.K.), The Ohio State University, Columbus, Ohio 43210"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parmeet K.","family":"Manchanda","sequence":"additional","affiliation":[{"name":"Departments of Molecular, Virology, Immunology, and Medical Genetics (M.Z., P.K.M., L.S.K.), The Ohio State University, Columbus, Ohio 43210"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayong","family":"Wu","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Biochemistry (D.W., Q.W.), The Ohio State University, Columbus, Ohio 43210"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianben","family":"Wang","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Biochemistry (D.W., Q.W.), The Ohio State University, Columbus, Ohio 43210"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence S.","family":"Kirschner","sequence":"additional","affiliation":[{"name":"Departments of Molecular, Virology, Immunology, and Medical Genetics (M.Z., P.K.M., L.S.K.), The Ohio State University, Columbus, Ohio 43210"},{"name":"Division of Endocrinology, Diabetes, and Metabolism (L.S.K.), The Ohio State University, Columbus, Ohio 43210"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071614165060400_B1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/002215549704500402","article-title":"Sequential expression of bone matrix proteins during rat calvaria osteoblast differentiation and bone nodule formation in vitro","volume":"45","author":"Nefussi","year":"1997","journal-title":"J Histochem Cytochem"},{"key":"2020071614165060400_B2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/BLO.0b013e31802b683c","article-title":"Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis","volume":"454","author":"Haydon","year":"2007","journal-title":"Clin Orthop Relat Res"},{"key":"2020071614165060400_B3","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1158\/0008-5472.CAN-05-0580","article-title":"A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues","volume":"65","author":"Kirschner","year":"2005","journal-title":"Cancer Res"},{"key":"2020071614165060400_B4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00000478-200102000-00004","article-title":"Osteochondromyxoma of bone: a congenital tumor associated with lentigines and other unusual disorders","volume":"25","author":"Carney","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"2020071614165060400_B5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-\u03b1 regulatory subunit in patients with the Carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat Genet"},{"key":"2020071614165060400_B6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2796.2009.02114.x","article-title":"Use of mouse models to understand the molecular basis of tissue-specific tumorigenesis in the Carney complex","volume":"266","author":"Kirschner","year":"2009","journal-title":"J Intern Med"},{"key":"2020071614165060400_B7","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/CIRCULATIONAHA.107.759233","article-title":"Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis","volume":"117","author":"Yin","year":"2008","journal-title":"Circulation"},{"key":"2020071614165060400_B8","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1210\/me.2009-0439","article-title":"Neural crest-specific loss of Prkar1a causes perinatal lethality resulting from defects in intramembranous ossification","volume":"24","author":"Jones","journal-title":"Mol Endocrinol"},{"key":"2020071614165060400_B9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/me.2007-0369","article-title":"Mutation of Prkar1a causes osteoblast neoplasia driven by dysregulation of protein kinase A","volume":"22","author":"Pavel","year":"2008","journal-title":"Mol Endocrinol"},{"key":"2020071614165060400_B10","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1210\/endo.140.7.6872","article-title":"3\u2032,5\u2032-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro","volume":"140","author":"Koh","year":"1999","journal-title":"Endocrinology"},{"key":"2020071614165060400_B11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jcb.23426","article-title":"Downregulation of PKD1 by shRNA results in defective osteogenic differentiation via cAMP\/PKA pathway in human MG-63 cells","volume":"113","author":"Qiu","year":"2012","journal-title":"J Cell Biochem"},{"key":"2020071614165060400_B12","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.1073\/pnas.1003680107","article-title":"Alternate protein kinase A activity identifies a unique population of stromal cells in adult bone","volume":"107","author":"Tsang","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614165060400_B13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.yexcr.2003.12.030","article-title":"Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow","volume":"295","author":"Tropel","year":"2004","journal-title":"Exp Cell Res"},{"key":"2020071614165060400_B14","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1210\/me.2011-1008","article-title":"Differential role of PKA catalytic subunits in mediating phenotypes caused by knockout of the Carney complex gene Prkar1a","volume":"25","author":"Yin","year":"2011","journal-title":"Mol Endocrinol"},{"key":"2020071614165060400_B15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell"},{"key":"2020071614165060400_B16","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1128\/MCB.15.4.1858","article-title":"Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene","volume":"15","author":"Ducy","year":"1995","journal-title":"Mol Cell Biol"},{"key":"2020071614165060400_B17","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1359\/jbmr.1999.14.9.1504","article-title":"Anabolic or catabolic responses of MC3T3\u2013E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment","volume":"14","author":"Schiller","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2020071614165060400_B18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11010-008-9801-x","article-title":"Osteoblastic MG-63 cell differentiation, contraction, and mRNA expression in stress-relaxed 3D collagen I gels","volume":"317","author":"Parreno","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"2020071614165060400_B19","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0022-3565(24)37688-8","article-title":"Regulation of cAMP-dependent protein kinase subunit expression in CATH.a and SH-SY5Y cells","volume":"286","author":"Boundy","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071614165060400_B20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/jmg.2004.028043","article-title":"A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions","volume":"41","author":"Griffin","year":"2004","journal-title":"J Med Genet"},{"key":"2020071614165060400_B21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/mcne.1994.1017","article-title":"Structural features of the murine gene encoding the RI\u03b2 subunit of cAMP-dependent protein kinase","volume":"5","author":"Clegg","year":"1994","journal-title":"Mol Cell Neurosci"},{"key":"2020071614165060400_B22","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.febslet.2009.02.040","article-title":"Identification and characterization of Runx2 phosphorylation sites involved in matrix metalloproteinase-13 promoter activation","volume":"583","author":"Selvamurugan","year":"2009","journal-title":"FEBS Lett"},{"key":"2020071614165060400_B23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bcmd.2010.03.002","article-title":"TEThered to Runx: novel binding partners for runx factors","volume":"45","author":"Li","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"2020071614165060400_B24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jcb.22263","article-title":"Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors","volume":"108","author":"Li","year":"2009","journal-title":"J Cell Biochem"},{"key":"2020071614165060400_B25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jcb.20805","article-title":"Transcriptional co-repressors of Runx2","volume":"98","author":"Westendorf","year":"2006","journal-title":"J Cell Biochem"},{"key":"2020071614165060400_B26","doi-asserted-by":"crossref","first-page":"30689","DOI":"10.1074\/jbc.M500750200","article-title":"Cooperative interactions between activating transcription factor 4 and Runx2\/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression","volume":"280","author":"Xiao","year":"2005","journal-title":"J Biol Chem"},{"key":"2020071614165060400_B27","doi-asserted-by":"crossref","first-page":"31055","DOI":"10.1074\/jbc.M109.079962","article-title":"Foxo1, a novel regulator of osteoblast differentiation and skeletogenesis","volume":"285","author":"Teixeira","year":"2010","journal-title":"J Biol Chem"},{"key":"2020071614165060400_B28","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1158\/0008-5472.CAN-10-2603","article-title":"FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion","volume":"71","author":"Zhang","journal-title":"Cancer Res"},{"key":"2020071614165060400_B29","doi-asserted-by":"crossref","first-page":"19149","DOI":"10.1074\/jbc.M110.197905","article-title":"Foxo1 mediates insulin-like growth factor 1 (IGF1)\/insulin regulation of osteocalcin expression by antagonizing Runx2 in osteoblasts","volume":"286","author":"Yang","journal-title":"J Biol Chem"},{"key":"2020071614165060400_B30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000185441","article-title":"The molecular basis of disorders caused by defects in G proteins","volume":"47","author":"Spiegel","year":"1997","journal-title":"Horm Res"},{"key":"2020071614165060400_B31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0006-291X(91)91339-E","article-title":"The activation of cAMP-dependent protein kinase is directly linked to the inhibition of osteoblast proliferation (UMR-106) by parathyroid hormone-related protein","volume":"179","author":"Kano","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071614165060400_B32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1359\/jbmr.1997.12.2.172","article-title":"Rapid protein kinase A-mediated activation of cyclic AMP-phosphodiesterase by parathyroid hormone in UMR-106 osteoblast-like cells","volume":"12","author":"Ahlstrom","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2020071614165060400_B33","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1073\/pnas.0711190105","article-title":"cAMP\/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo","volume":"105","author":"Siddappa","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614165060400_B34","first-page":"1587","article-title":"Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation","volume":"151","author":"Riminucci","year":"1997","journal-title":"Am J Pathol"},{"key":"2020071614165060400_B35","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1055\/s-0032-1321845","article-title":"Different roles of GNAS and cAMP signaling during early and late stages of osteogenic differentiation","volume":"44","author":"Zhang","year":"2012","journal-title":"Horm Metab Res"},{"key":"2020071614165060400_B36","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1172\/JCI46406","article-title":"Gs\u03b1 enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice","volume":"121","author":"Wu","journal-title":"J Clin Invest"},{"key":"2020071614165060400_B37","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1172\/JCI42391","article-title":"Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice","volume":"120","author":"Molyneux","journal-title":"J Clin Invest"},{"key":"2020071614165060400_B38","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","article-title":"Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts","volume":"89","author":"Komori","year":"1997","journal-title":"Cell"},{"key":"2020071614165060400_B39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","article-title":"The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation","volume":"108","author":"Nakashima","year":"2002","journal-title":"Cell"},{"key":"2020071614165060400_B40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrm3254","article-title":"Building strong bones: molecular regulation of the osteoblast lineage","volume":"13","author":"Long","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2020071614165060400_B41","doi-asserted-by":"crossref","first-page":"16502","DOI":"10.1074\/jbc.M512494200","article-title":"Bone morphogenetic protein-2 stimulates Runx2 acetylation","volume":"281","author":"Jeon","year":"2006","journal-title":"J Biol Chem"},{"key":"2020071614165060400_B42","doi-asserted-by":"crossref","first-page":"28875","DOI":"10.1074\/jbc.274.41.28875","article-title":"Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin\/proteasome-dependent regulation","volume":"274","author":"Tintut","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071614165060400_B43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cmet.2010.01.001","article-title":"FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts","volume":"11","author":"Rached","journal-title":"Cell Metab"},{"key":"2020071614165060400_B44","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.bone.2011.01.019","article-title":"FOXO1 modulates osteoblast differentiation","volume":"48","author":"Siqueira","journal-title":"Bone"},{"key":"2020071614165060400_B45","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1074\/jbc.M110.180661","article-title":"Protein kinase A-\u03b1 directly phosphorylates FoxO1 in vascular endothelial cells to regulate expression of vascular cellular adhesion molecule-1 mRNA","volume":"286","author":"Lee","journal-title":"J Biol Chem"},{"key":"2020071614165060400_B46","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature03398","article-title":"Leptin regulation of bone resorption by the sympathetic nervous system and CART","volume":"434","author":"Elefteriou","year":"2005","journal-title":"Nature"},{"key":"2020071614165060400_B47","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1172\/JCI64906","article-title":"FOXO1 orchestrates the bone-suppressing function of gut-derived serotonin","volume":"122","author":"Kode","year":"2012","journal-title":"J Clin Invest"},{"key":"2020071614165060400_B48","doi-asserted-by":"crossref","first-page":"8757","DOI":"10.1074\/jbc.M111.282897","article-title":"FoxO1 protein cooperates with ATF4 protein in osteoblasts to control glucose homeostasis","volume":"287","author":"Kode","journal-title":"J Biol Chem"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/28\/3\/295\/8902727\/mend0295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/28\/3\/295\/8902727\/mend0295.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T20:18:36Z","timestamp":1746130716000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/28\/3\/295\/2623199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,1]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2013-1152","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,1]]}}}